Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading update

9 Nov 2015 15:57

RNS Number : 0909F
Imaginatik PLC
09 November 2015
Β 

9 November 2015

Imaginatik Plc

Β 

("Imaginatik" or "the Company")

Β 

Trading Update

Β 

Β 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of consultancy and technology products, provides a trading update covering the first half of the Company's financial year to 30 September 2015.

Β 

The Company expects to report an increase in recognised revenues of approximately 33% to Β£1.96m (2014: Β£1.47m). This increase combined with the containment of costs will reduce the half year losses to approximately Β£0.41m (2014: Β£0.70m). Particularly encouraging is the increase of approximately 91% in overall bookings in the period to Β£1.97m (2014: Β£1.03m at constant currency). This has been driven primarily by the successful completion of several large multi-year renewals with existing clients. We are pleased to report that we renewed 14 out of the 17 contracts available for renewal and secured 87% of the available renewal revenues in the period.

Β 

In addition, we closed contracts in the period with several new clients including Eli Lilly, Landauer and Alaska Air.

Β 

We are also pleased to report continued progress in the Consulting division, including successfully growing our footprint with several existing customers and expanding the range of our consultancy engagements to include portfolio valuation work, the creation of long term strategy for creating deep innovation capabilities as well as our more traditional consulting support work with our Innovation Central technology platform.

Β 

As we enter the second half of the year, we are currently in contract discussions with a number of other companies and expect to complete several new contracts in the next few weeks. We expect the momentum in the Consulting division to continue, with several new consulting opportunities being developed. There is an equally large number of clients available to renew with us in the second half of the year and we are working diligently to achieve a similar or better result than that achieved in the first half year.

Β 

As stated in previous announcements, as a small company with relatively few high value contracts, the management of cash resources can at times be a challenge. During the period the Company's Chairman, Matt Cooper, advanced the Company $110,000 as a short term loan, of which $50,000 has now been repaid. The balance of this loan together with the balance of the $250,000 loan advanced in January 2015 is scheduled to be repaid over the coming months. The Company will continue to carefully manage its cash reserves and will be considering its various funding options to ensure that the business maintains sufficient levels of investment during this growth phase.

Β 

Matt Cooper, Non-Executive Chairman, commented: "The Board is pleased with the progress Imaginatik is making. The quality of the client base is outstanding for a company of our size and we are seeing pleasing growth in new innovation consulting opportunities."

Β 

Β 

The Company expects to report interim results for the six month period to 30 September 2015 in early December.

Β 

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls

Daniel Stewart & Company

Tel: 020 7776 6550

Martin Lampshire/David Coffman

Alma PR

Tel: 020 7796 9085

Hilary Buchanan

Β 

About Imaginatik

Β 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visitΒ www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUGGWAGUPAGAB
Date   Source Headline
25th Jan 201211:30 amRNSHolding(s) in Company
23rd Jan 20127:01 amRNSContract Renewals worth £1.1m
3rd Jan 20127:00 amRNSDirectorate Change
22nd Dec 20117:00 amRNSContract extension
14th Dec 20117:00 amRNSLitigation Update
12th Dec 20117:00 amRNSContract Win
28th Nov 20117:00 amRNSHalf Yearly Report
28th Oct 20112:13 pmRNSChange of Adviser
28th Oct 201110:02 amRNSHolding(s) in Company
27th Oct 201110:45 amRNSHolding(s) in Company
13th Oct 20117:00 amRNSContract Extension
3rd Oct 201112:28 pmRNSDirectorate Change
26th Sep 20115:12 pmRNSResult of AGM
15th Sep 201110:24 amRNSHolding(s) in Company
2nd Sep 20113:25 pmRNSNotice of AGM
31st Aug 201111:46 amRNSHolding(s) in Company
26th Aug 20113:30 pmRNSResult of Open Offer and General Meeting
4th Aug 20119:32 amRNSPosting of Circular
2nd Aug 20117:15 amRNSProposed Placing, Subscription and Open Offer
2nd Aug 20117:00 amRNSFinal Results
29th Jul 201112:10 pmRNSNotice of Results
26th Apr 20117:00 amRNSIssue of Equity
14th Apr 20117:00 amRNSContract with the World Bank
1st Mar 20117:00 amRNSContract Wins and Trading Update
25th Jan 201111:22 amRNSWithdrawal of requisition of General Meeting
12th Jan 201111:01 amRNSHolding(s) in Company
11th Jan 20115:26 pmRNSIssue of Equity
22nd Dec 201012:24 pmRNSResult of General Meeting
22nd Dec 20107:00 amRNSFurther Requisition of General Meeting
16th Dec 20107:00 amRNSHalf Yearly Report
1st Dec 201010:08 amRNSNotice of General Meeting
19th Nov 20107:00 amRNSBoard Appointment
15th Nov 20103:28 pmRNSRequisition of General Meeting
11th Oct 20107:00 amRNSContract Extension with Pfizer
4th Oct 201011:58 amRNSShare Option Schemes
29th Sep 201011:41 amRNSResult of AGM
29th Sep 20107:00 amRNSAGM Statement
10th Sep 20105:00 pmRNSHolding in Company
10th Sep 20103:36 pmRNSHolding(s) in Company
10th Sep 20107:00 amRNSPilot Project Established with NASA
9th Sep 201012:47 pmRNSHolding(s) in Company
6th Sep 20104:14 pmRNSIssue of Equity
24th Aug 20103:16 pmRNSResult of General Meeting
18th Aug 20101:23 pmRNSMarket Update
6th Aug 20106:28 pmRNSPosting of Circular
30th Jul 20104:41 pmRNSHolding(s) in Company
27th Jul 20104:33 pmRNSPosting of Circular convening General Meeting
22nd Jul 201011:53 amRNSHolding(s) in Company
7th Jul 201011:04 amRNSSenior Management Team Appointments
23rd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.